Skip to content

Dokter Karin Vanhoonacker

Active
Private limited companyfounded 201016 yrs activePullewouwe 84, 1730 Asse, BelgiumKBO/BCE: BE 0825.136.339

Dokter Karin Vanhoonacker has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €339k and a net result of €78k. Equity is growing by ~13.2% per year across the filed fiscal years. Its solvency ranks better than 60% of 16491 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Checked score

Score 2025
94 / 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability89▼-6
Solvency98▼-2
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €30k at 30 days acceptable
Liquidity ample (current ratio 3.49 against 12.79 in 2024; short-term debt: 27.3% and cash: 82.7% of total assets), and 27.4% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
72.6%
Return on assets
16.6%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 16 years 0 20 y
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-07-2026, 18 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
18 d early
2024
22 d late
2023
12 d early
2022
12 d early
2021
18 d early
2020
32 d early
2019
12 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
19-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€339k▼ 7.2%
2024 · €366k
2018: €165k 2019: €155k 2020: €185k 2021: €224k 2022: €250k 2023: €292k 2024: €366k
2018 → 2025
Total assets
€468k▲ 18.1%
2024 · €396k
2018: €184k 2019: €192k 2020: €190k 2021: €252k 2022: €271k 2023: €333k 2024: €396k
2018 → 2025
Net result
€78k▼ 14.8%
2024 · €91k
2018: €17k 2019: €15k 2020: €30k 2021: €59k 2022: €33k 2023: €55k 2024: €91k
2018 → 2025
Working capital
€317k▼ 8.8%
2024 · €348k
2018: €139k 2019: €108k 2020: €141k 2021: €187k 2022: €218k 2023: €273k 2024: €348k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€224k-€250k▲ 11.6%€292k▲ 16.8%€366k▲ 25.4%€339k▼ 7.2%
Operating result€82k-€50k▼ 39.1%€78k▲ 56.1%€124k▲ 59.4%€107k▼ 13.3%
Net result€59k-€33k▼ 43.4%€55k▲ 63.0%€91k▲ 66.9%€78k▼ 14.8%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50k€100kOperating result 2021: €82k€82kNet result 2021: €59k€59kOperating result 2022: €50k€50kNet result 2022: €33k€33kOperating result 2023: €78k€78kNet result 2023: €55k€55kOperating result 2024: €124k€124kNet result 2024: €91k€91kOperating result 2025: €107k€107kNet result 2025: €78k€78k20212022202320242025
The operating result falls in 2025; 2025 is 13% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €468k
Fixed assets €23k▲ 24.3%
Current assets €444k▲ 17.8%
Equity and liabilities €468k
Equity €339k▼ 7.2%
Debt €128k▲ 326%
The debt ratio rises from 7.6% to 27.4%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€112k
2024 · €128k
Cash flow
€82k
2024 · €95k
Solvency
72.6%
2024 · 92.4%
Current ratio
3.49
2024 · 12.79
Quick ratio
3.49
2024 · 12.79
Debt / equity
0.38
2024 · 0.08
ROE
22.9%
2024 · 24.9%
ROA
16.6%
2024 · 23.0%
Interest coverage
143.36
2024 · -97.00
Debt
€128k
2024 · €30k
Debt ≤ 1 year
€127k
2024 · €29k
Income taxes
€31k
2024 · €37k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€396k€468k
Fixed assets21/28€19k€23k
Tangible fixed assets22/27€17k€22k
Plant, machinery and equipment23€3k€4k
Furniture and vehicles24€13k€17k
Other tangible fixed assets26€1k€733
Financial fixed assets28€1k€1k=
Current assets29/58€377k€444k
Amounts receivable within one year40/41€21k€19k
Trade receivables40€18k€10k
Other amounts receivable41€3k€9k
Current investments50/53€32k€35k
Cash at bank and in hand54/58€321k€387k
Deferred charges and accrued income490/1€4k€3k
Equity and liabilities
Total equity and liabilities10/49€396k€468k
Equity10/15€366k€339k
Contributions10/11€12k€12k=
Reserves13€284k€258k
Tax-exempt reserves132€520€520=
Distributable reserves133€284k€257k
Profit (loss) carried forward14€69k€69k
Amounts payable17/49€30k€128k
Amounts payable within one year42/48€29k€127k
Trade debts44€941€720
Suppliers440/4€941€720
Taxes, remuneration and social security45€12k€6k
Taxes450/3€12k€6k
Other amounts payable47/48€17k€120k
Accrued charges and deferred income492/3€596€611
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€4k€5k
Other operating charges640/8€637€2k
Gross operating margin9900€129k€114k
Operating profit (loss)9901€124k€107k
Financial income75/76B€3k€2k
Recurring financial income75€3k€2k
Financial charges65/66B€-1k€782
Recurring financial charges65€-1k€782
Profit (loss) for the period before taxes9903€128k€109k
Income taxes67/77€37k€31k
Profit (loss) for the period9904€91k€78k
Profit (loss) for the period to be appropriated9905€91k€78k
Appropriation of the result
Profit (loss) to be appropriated9906€160k€147k
Profit (loss) brought forward from the previous period14P€69k€69k=
Transfer from equity791/2€17k€104k
Transfer to equity691/2€91k€78k
To other reserves6921€91k€78k
Profit to be distributed694/7€17k€104k
Return on contributions (dividend)694€17k€104k

The notes to these accounts (12 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
13-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
22-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 22 days late
2024
31-12
Financial Highest result since 2018net €91k ▲66.9%
Operating result €124k, net result €91k, both a record.
19-07
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
19-07
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
13-07
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial Equity above €200kEq €224k ▲21.2%
4 profitable years in a row build equity to €224k.
29-06
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial Liquidity times 7current ratio 27.95
Current ratio from 3.90 to 27.95; short-term debt falls from €37k to €5k.
19-07
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
2019
31-12
Financial Weakest financial yearnet €15k ▼11.8%
Net result drops to €15k, the lowest in the series; recovery starts the following year.
23-08
NBB filing Annual accounts filed
fiscal year 2018 · micro schema · 23 days late
2018
27-08
NBB filing Annual accounts filed
fiscal year 2017 · micro schema · 27 days late
2017
29-08
NBB filing Annual accounts filed
fiscal year 2016 · micro schema · 29 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Asse · 1 establishment unit since 2010
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Pullewouwe 841730 Asse
Ground area
2,374 m²
Building footprint
231 m²
Volume, LiDAR
1,130 m³
Parcel 23002H0782/00B000, Flanders · tallest building 10.7 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
DOKTER VANHOONACKER
Pullewouwe 84, 1730 AsseGeneral medical practice
since 20102.187.918.637
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
23002H0782/00B000 Flanders 2,374 m² 1 · 231 m² 10.7 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Public money · subsidies and aid

Flemish government

2023 · 1 entry · 51 EUR awarded · 51 EUR paid
Year Entries awardedpaid
2023 1 51 EUR51 EUR
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
1 entry · 51 EUR · 51 EUR paid · Fonds voor Innoveren en Ondernemen

Similar companies · same sector, comparable size

Of 9,120 companies in sector 86210 we hold annual accounts for 6,336. 5,165 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded19-04-2010
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 16 filingsAddress and cadastre registers

Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.